Multistrain Probiotic

DIETARY_SUPPLEMENT5 trials

Sponsors

Larena SAS, Università degli Studi di Ferrara, University of Calgary, The Archer-Daniels-Midland Company, Oslo University Hospital

Conditions

Allergic RhinitisCancerCystic Fibrosis in ChildrenGastrointestinal DysfunctionIBS - Irritable Bowel SyndromeInfluenzaPsychosocial Problem

Unknown Phase

Effect of Lactibiane Tolerance® to Treat Leaky Gut in Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)Patients

CompletedNCT04898257

Larena SASIBS - Irritable Bowel Syndrome

Start: 2018-05-17End: 2020-11-25Updated: 2021-05-24

Effect of a Multistrain Probiotic on Allergic Rhinitis Symptoms and Gut Microbiota Composition in Atopic Patients

CompletedNCT05344352

Università degli Studi di FerraraAllergic Rhinitis

Start: 2022-03-30End: 2024-06-30Updated: 2024-12-06

The Chemo-Gut Probiotic Trial for Cancer Survivors

University of CalgaryCancer, Gastrointestinal Dysfunction, Psychosocial Problem

Start: 2023-11-10End: 2025-09-30Target: 66Updated: 2023-10-18

Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination

CompletedNCT06103994

The Archer-Daniels-Midland CompanyInfluenza

Start: 2023-10-27End: 2024-01-12Updated: 2025-04-10

Quality of Life and Gut Health in Pediatric Patients With Cystic Fibrosis

RecruitingNCT06284577

Oslo University HospitalCystic Fibrosis in Children

Start: 2024-01-02End: 2027-07-01Target: 40Updated: 2024-06-13

Related Papers

Clinical Efficacy of Probiotics for Allergic Rhinitis: Results of an Exploratory Randomized Controlled Trial

Nutrients2024-11-3013 citations